Multiple Myeloma
This book deals with the diagnosis and treatment of multiple myeloma. Multiple myeloma is a plasma cell disorder, the prognosis of which has dramatically improved in the last years thanks to new immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, in relapsed/refractory disease...
Saved in:
| 格式: | Online |
|---|---|
| 語言: | 英语 |
| 出版: |
IntechOpen
2023
|
| 主題: | |
| 在線閱讀: | ONIX_20231201_9781839686214_2104 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
| _version_ | 1869529050536476672 |
|---|---|
| collection | Directory of Open Access Books |
| description | This book deals with the diagnosis and treatment of multiple myeloma. Multiple myeloma is a plasma cell disorder, the prognosis of which has dramatically improved in the last years thanks to new immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, in relapsed/refractory disease and a diagnosis. Chapters cover such topics as prognostic and predictive factors in newly diagnosed multiple myeloma, treatment approaches, antibody therapies, and three-dimensional (3D) models mimicking multiple myeloma bone marrow–microenvironment interactions. |
| format | Online |
| id | doab-20.500.12854ir-130993 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | IntechOpen |
| publisherStr | IntechOpen |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1309932024-03-31T22:43:40Z Multiple Myeloma Fuchs, Ota daratumumab, tumor microenvironment, monoclonal antibodies, monoclonal antibody, overall survival, prognostic factors thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology This book deals with the diagnosis and treatment of multiple myeloma. Multiple myeloma is a plasma cell disorder, the prognosis of which has dramatically improved in the last years thanks to new immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, in relapsed/refractory disease and a diagnosis. Chapters cover such topics as prognostic and predictive factors in newly diagnosed multiple myeloma, treatment approaches, antibody therapies, and three-dimensional (3D) models mimicking multiple myeloma bone marrow–microenvironment interactions. 2023-12-01T18:38:20Z 2023-12-01T18:38:20Z 2021 book ONIX_20231201_9781839686214_2104 9781839686214 9781839686207 9781839686221 https://directory.doabooks.org/handle/20.500.12854/130993 eng image/jpeg n/a https://www.intechopen.com/books/9791 https://mts.intechopen.com/storage/books/9791/authors_book/authors_book.pdf IntechOpen IntechOpen 10.5772/intechopen.87599 10.5772/intechopen.87599 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9781839686214 9781839686207 9781839686221 IntechOpen 126 open access |
| spellingShingle | daratumumab, tumor microenvironment, monoclonal antibodies, monoclonal antibody, overall survival, prognostic factors thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Multiple Myeloma |
| title | Multiple Myeloma |
| title_full | Multiple Myeloma |
| title_fullStr | Multiple Myeloma |
| title_full_unstemmed | Multiple Myeloma |
| title_short | Multiple Myeloma |
| title_sort | multiple myeloma |
| topic | daratumumab, tumor microenvironment, monoclonal antibodies, monoclonal antibody, overall survival, prognostic factors thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| topic_facet | daratumumab, tumor microenvironment, monoclonal antibodies, monoclonal antibody, overall survival, prognostic factors thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| url | ONIX_20231201_9781839686214_2104 |